Sanara MedTech (SMTI) Long-Term Investments (2018 - 2025)
Sanara MedTech (SMTI) has disclosed Long-Term Investments for 7 consecutive years, with $12.6 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Long-Term Investments rose 51.28% year-over-year to $12.6 million, compared with a TTM value of $12.6 million through Sep 2025, up 51.28%, and an annual FY2024 reading of $6.2 million, up 101.44% over the prior year.
- Long-Term Investments was $12.6 million for Q3 2025 at Sanara MedTech, up from $10.5 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $12.6 million in Q3 2025 and bottomed at $1.6 million in Q1 2021.
- Average Long-Term Investments over 5 years is $4.9 million, with a median of $3.1 million recorded in 2022.
- The sharpest move saw Long-Term Investments surged 662.31% in 2021, then tumbled 38.53% in 2022.
- Year by year, Long-Term Investments stood at $5.0 million in 2021, then crashed by 38.53% to $3.1 million in 2022, then changed by 0.0% to $3.1 million in 2023, then soared by 101.44% to $6.2 million in 2024, then skyrocketed by 102.62% to $12.6 million in 2025.
- Business Quant data shows Long-Term Investments for SMTI at $12.6 million in Q3 2025, $10.5 million in Q2 2025, and $10.7 million in Q1 2025.